Royal Bank Of Canada Immucell Corp Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.18 - $5.48 $271 - $356	65 Added 112.07%	123 $0
Q1 2024 Nov 05, 2024	SELL	$4.73 - $5.47 $307 - $355	-65 Reduced 52.85%	58 $0
Q1 2024 May 15, 2024	SELL	$4.73 - $5.47 $709 - $820	-150 Reduced 72.12%	58 $0
Q4 2023 Feb 14, 2024	BUY	$4.45 - $5.47 $805 - $990	181 Added 670.37%	208 $1,000
Q3 2023 Nov 14, 2023	SELL	$4.53 - $5.61 $969 - $1,200	-214 Reduced 88.8%	27 $0
Q2 2023 Aug 14, 2023	BUY	$4.64 - $5.98 $1,118 - $1,441	241 New	241 $1,000

1.15M

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $40.6M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.